Issues and legislation related to (1) Medicare coverage of anti-obesity medications, (2) the 340B drug pricing program, and (3) Medicare Part D coverage of anti-obesity medications; and other specific legislation
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2023: U.S. Senate, House of Representatives, Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS)
Related Foreign Entities:
Novo Nordisk A/S (Bagsvrd, DEN); contribution to lobbying: $0; ownership 100%; Novo Holdings A/S (through ownership in Novo Nordisk A/S) (Hellerup, DEN); contribution to lobbying: $0; ownership 28%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Special Advisor, CISA 2021-2022; Legislative Aide, Office of Rep. Cedric Richmond 2018-2021; Digital Press Secretary, Office of Rep. Val Demings 2018; Legislative Intern, Office of Rep. Cedric Richmond 2017
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Q3 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...